Comparison of the clinical syndromes of anti-GABAa versus anti-GABAb associated autoimmune encephalitis: A systematic review

J Neuroimmunol. 2022 Feb 15:363:577804. doi: 10.1016/j.jneuroim.2021.577804. Epub 2021 Dec 30.

Abstract

The main objective of this article is to improve our understanding of the differences and similarities of these two anti-gamma-aminobutyric acid receptor encephalitis, anti-GABAaR and anti-GABAbR. The data were systematically collected and we found 26 studies: seven studies and 37 patients corresponded to anti-GABAaR encephalitis, and 21 manuscripts and 116 patients were diagnosed with anti-GABAbR encephalitis. Both anti-GABAR encephalitis were marked by prominent seizures. Anti-GABAaR patients were younger and showed multifocal encephalitis. On the other hand, anti-GABAbR patients were older and showed temporal limbic encephalitis. Tumor occurred in a fifth of anti-GABAaR encephalitis and in half of anti-GABAbR encephalitis. The main tumor associated with anti-GABAbR encephalitis is SCLC, whereas the most common tumor associated with anti-GABAaR encephalitis was thymoma. Our data confirms the differences in clinical features between both encephalitis.

Keywords: Anti-GABAaR encephalitis; Anti-GABAbR encephalitis; Autoimmune encephalitis; GABA receptors; Systematic review.

Publication types

  • Comparative Study
  • Systematic Review

MeSH terms

  • Autoantibodies / immunology*
  • Autoantigens / immunology*
  • Autoimmune Diseases / immunology*
  • Encephalitis / immunology*
  • Humans
  • Receptors, GABA-A / immunology*
  • Receptors, GABA-B / immunology*
  • Syndrome

Substances

  • Autoantibodies
  • Autoantigens
  • Receptors, GABA-A
  • Receptors, GABA-B